0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccine Adjuvants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: August 2021
|
Report Code: QYRE-Othe-2172
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Vaccine Adjuvants Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Vaccine Adjuvants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Othe-2172
Report
August 2021
117 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The top five global manufacturers of vaccine adjuvants are GSK, CSL Limited, Brenntag Biosector, Seppic and SPI Pharma, with a combined market share of about 70 per cent. Europe is the largest consumption place, with a consumption market share nearly 43% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 30%.
Market Analysis and Insights: Global Vaccine Adjuvants Market

In 2020, the global Vaccine Adjuvants market size was US$ 762 million and it is expected to reach US$ 1503.9 million by the end of 2027, with a CAGR of 10.2% during 2021-2027.

Global Vaccine Adjuvants Scope and Market Size
Vaccine Adjuvants market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Vaccine Adjuvants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Vaccine Adjuvants market is segmented into

Oral
Subcutaneous
Intramuscular
Others

Segment by Application, the Vaccine Adjuvants market is segmented into

Human Vaccine Adjuvants
Veterinary Vaccine Adjuvants
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape and Vaccine Adjuvants Market Share Analysis
Vaccine Adjuvants market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Vaccine Adjuvants product introduction, recent developments, Vaccine Adjuvants sales by region, type, application and by sales channel.
The major companies include:
SEPPIC
SDA BIO
Brenntag Biosector
SPI Pharma
MVP Laboratories
Tj Kaiwei
Novavax
Zhuoyue
Aphios
1 Study Coverage
1.1 Vaccine Adjuvants Product Introduction
1.2 Market by Type
1.2.1 Global Vaccine Adjuvants Market Size Growth Rate by Type
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaccine Adjuvants Market Size Growth Rate by Application
1.3.2 Human Vaccine Adjuvants
1.3.3 Veterinary Vaccine Adjuvants
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccine Adjuvants Market Size Estimates and Forecasts
2.1.1 Global Vaccine Adjuvants Revenue 2016-2027
2.1.2 Global Vaccine Adjuvants Sales 2016-2027
2.2 Vaccine Adjuvants Market Size by Region: 2021 Versus 2027
2.3 Vaccine Adjuvants Sales by Region (2016-2027)
2.3.1 Global Vaccine Adjuvants Sales by Region: 2016-2021
2.3.2 Global Vaccine Adjuvants Sales Forecast by Region (2022-2027)
2.3.3 Global Vaccine Adjuvants Sales Market Share by Region (2016-2027)
2.4 Vaccine Adjuvants Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Vaccine Adjuvants Revenue by Region: 2016-2021
2.4.2 Global Vaccine Adjuvants Revenue Forecast by Region (2022-2027)
2.4.3 Global Vaccine Adjuvants Revenue Market Share by Region (2016-2027)
3 Global Vaccine Adjuvants by Manufacturers
3.1 Global Top Vaccine Adjuvants Manufacturers by Sales
3.1.1 Global Vaccine Adjuvants Sales by Manufacturer (2016-2021)
3.1.2 Global Vaccine Adjuvants Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Vaccine Adjuvants Manufacturers by Revenue
3.2.1 Global Vaccine Adjuvants Revenue by Manufacturer (2016-2021)
3.2.2 Global Vaccine Adjuvants Revenue Share by Manufacturer (2016-2021)
3.3 Global Vaccine Adjuvants Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Vaccine Adjuvants Manufacturers Covered: Ranking by Revenue
3.4.2 Global Vaccine Adjuvants Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Vaccine Adjuvants Manufacturing Base Distribution, Product Type
3.5.1 Vaccine Adjuvants Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Vaccine Adjuvants Product Type
3.5.3 Date of International Manufacturers Enter into Vaccine Adjuvants Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 SEPPIC
4.1.1 SEPPIC Corporation Information
4.1.2 SEPPIC Description, Business Overview
4.1.3 SEPPIC Vaccine Adjuvants Products Offered
4.1.4 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
4.1.5 SEPPIC Vaccine Adjuvants Revenue by Product
4.1.6 SEPPIC Vaccine Adjuvants Revenue by Application
4.1.7 SEPPIC Vaccine Adjuvants Revenue by Geographic Area
4.1.8 SEPPIC Vaccine Adjuvants Revenue by Sales Channel
4.1.9 SEPPIC Recent Development
4.2 SDA BIO
4.2.1 SDA BIO Corporation Information
4.2.2 SDA BIO Description, Business Overview
4.2.3 SDA BIO Vaccine Adjuvants Products Offered
4.2.4 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
4.2.5 SDA BIO Vaccine Adjuvants Revenue by Product
4.2.6 SDA BIO Vaccine Adjuvants Revenue by Application
4.2.7 SDA BIO Vaccine Adjuvants Revenue by Geographic Area
4.2.8 SDA BIO Vaccine Adjuvants Revenue by Sales Channel
4.2.9 SDA BIO Recent Development
4.3 Brenntag Biosector
4.3.1 Brenntag Biosector Corporation Information
4.3.2 Brenntag Biosector Description, Business Overview
4.3.3 Brenntag Biosector Vaccine Adjuvants Products Offered
4.3.4 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Brenntag Biosector Vaccine Adjuvants Revenue by Product
4.3.6 Brenntag Biosector Vaccine Adjuvants Revenue by Application
4.3.7 Brenntag Biosector Vaccine Adjuvants Revenue by Geographic Area
4.3.8 Brenntag Biosector Vaccine Adjuvants Revenue by Sales Channel
4.3.9 Brenntag Biosector Recent Development
4.4 SPI Pharma
4.4.1 SPI Pharma Corporation Information
4.4.2 SPI Pharma Description, Business Overview
4.4.3 SPI Pharma Vaccine Adjuvants Products Offered
4.4.4 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
4.4.5 SPI Pharma Vaccine Adjuvants Revenue by Product
4.4.6 SPI Pharma Vaccine Adjuvants Revenue by Application
4.4.7 SPI Pharma Vaccine Adjuvants Revenue by Geographic Area
4.4.8 SPI Pharma Vaccine Adjuvants Revenue by Sales Channel
4.4.9 SPI Pharma Recent Development
4.5 MVP Laboratories
4.5.1 MVP Laboratories Corporation Information
4.5.2 MVP Laboratories Description, Business Overview
4.5.3 MVP Laboratories Vaccine Adjuvants Products Offered
4.5.4 MVP Laboratories Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
4.5.5 MVP Laboratories Vaccine Adjuvants Revenue by Product
4.5.6 MVP Laboratories Vaccine Adjuvants Revenue by Application
4.5.7 MVP Laboratories Vaccine Adjuvants Revenue by Geographic Area
4.5.8 MVP Laboratories Vaccine Adjuvants Revenue by Sales Channel
4.5.9 MVP Laboratories Recent Development
4.6 Tj Kaiwei
4.6.1 Tj Kaiwei Corporation Information
4.6.2 Tj Kaiwei Description, Business Overview
4.6.3 Tj Kaiwei Vaccine Adjuvants Products Offered
4.6.4 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Tj Kaiwei Vaccine Adjuvants Revenue by Product
4.6.6 Tj Kaiwei Vaccine Adjuvants Revenue by Application
4.6.7 Tj Kaiwei Vaccine Adjuvants Revenue by Geographic Area
4.6.8 Tj Kaiwei Recent Development
4.7 Novavax
4.7.1 Novavax Corporation Information
4.7.2 Novavax Description, Business Overview
4.7.3 Novavax Vaccine Adjuvants Products Offered
4.7.4 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Novavax Vaccine Adjuvants Revenue by Product
4.7.6 Novavax Vaccine Adjuvants Revenue by Application
4.7.7 Novavax Vaccine Adjuvants Revenue by Geographic Area
4.7.8 Novavax Recent Development
4.8 Zhuoyue
4.8.1 Zhuoyue Corporation Information
4.8.2 Zhuoyue Description, Business Overview
4.8.3 Zhuoyue Vaccine Adjuvants Products Offered
4.8.4 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Zhuoyue Vaccine Adjuvants Revenue by Product
4.8.6 Zhuoyue Vaccine Adjuvants Revenue by Application
4.8.7 Zhuoyue Vaccine Adjuvants Revenue by Geographic Area
4.8.8 Zhuoyue Recent Development
4.9 Aphios
4.9.1 Aphios Corporation Information
4.9.2 Aphios Description, Business Overview
4.9.3 Aphios Vaccine Adjuvants Products Offered
4.9.4 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2016-2021)
4.9.5 Aphios Vaccine Adjuvants Revenue by Product
4.9.6 Aphios Vaccine Adjuvants Revenue by Application
4.9.7 Aphios Vaccine Adjuvants Revenue by Geographic Area
4.9.8 Aphios Recent Development
5 Breakdown Data by Type
5.1 Global Vaccine Adjuvants Sales by Type (2016-2027)
5.1.1 Global Vaccine Adjuvants Sales by Type (2016-2021)
5.1.2 Global Vaccine Adjuvants Sales Forecast by Type (2022-2027)
5.1.3 Global Vaccine Adjuvants Sales Market Share by Type (2016-2027)
5.2 Global Vaccine Adjuvants Revenue Forecast by Type (2016-2027)
5.2.1 Global Vaccine Adjuvants Revenue by Type (2016-2021)
5.2.2 Global Vaccine Adjuvants Revenue Forecast by Type (2022-2027)
5.2.3 Global Vaccine Adjuvants Revenue Market Share by Type (2016-2027)
5.3 Vaccine Adjuvants Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Vaccine Adjuvants Sales by Application (2016-2027)
6.1.1 Global Vaccine Adjuvants Sales by Application (2016-2021)
6.1.2 Global Vaccine Adjuvants Sales Forecast by Application (2022-2027)
6.1.3 Global Vaccine Adjuvants Sales Market Share by Application (2016-2027)
6.2 Global Vaccine Adjuvants Revenue Forecast by Application (2016-2027)
6.2.1 Global Vaccine Adjuvants Revenue by Application (2016-2021)
6.2.2 Global Vaccine Adjuvants Revenue Forecast by Application (2022-2027)
6.2.3 Global Vaccine Adjuvants Revenue Market Share by Application (2016-2027)
6.3 Vaccine Adjuvants Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Vaccine Adjuvants Market Size YoY Growth 2016-2027
7.2 North America Vaccine Adjuvants Market Facts & Figures by Country
7.2.1 North America Vaccine Adjuvants Sales by Country (2016-2027)
7.2.2 North America Vaccine Adjuvants Revenue by Country (2016-2027)
7.3 North America Vaccine Adjuvants Sales by Type
7.4 North America Vaccine Adjuvants Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Adjuvants Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Vaccine Adjuvants Market Facts & Figures by Region
8.2.1 Asia-Pacific Vaccine Adjuvants Sales by Region (2016-2027)
8.2.2 Asia-Pacific Vaccine Adjuvants Revenue by Region (2016-2027)
8.3 Asia-Pacific Vaccine Adjuvants Sales by Type
8.4 Asia-Pacific Vaccine Adjuvants Sales by Application
9 Europe
9.1 Europe Vaccine Adjuvants Market Size YoY Growth 2016-2027
9.2 Europe Vaccine Adjuvants Market Facts & Figures by Country
9.2.1 Europe Vaccine Adjuvants Sales by Country (2016-2027)
9.2.2 Europe Vaccine Adjuvants Revenue by Country (2016-2027)
9.3 Europe Vaccine Adjuvants Sales by Type
9.4 Europe Vaccine Adjuvants Sales by Application
10 Latin America
10.1 Latin America Vaccine Adjuvants Market Size YoY Growth 2016-2027
10.2 Latin America Vaccine Adjuvants Market Facts & Figures by Country
10.2.1 Latin America Vaccine Adjuvants Sales by Country (2016-2027)
10.2.2 Latin America Vaccine Adjuvants Revenue by Country (2016-2027)
10.3 Latin America Vaccine Adjuvants Sales by Type
10.4 Latin America Vaccine Adjuvants Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Vaccine Adjuvants Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Vaccine Adjuvants Market Facts & Figures by Country
11.2.1 Middle East and Africa Vaccine Adjuvants Sales by Country (2016-2027)
11.2.2 Middle East and Africa Vaccine Adjuvants Revenue by Country (2016-2027)
11.3 Middle East and Africa Vaccine Adjuvants Sales by Type
11.4 Middle East and Africa Vaccine Adjuvants Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Vaccine Adjuvants Supply Chain Analysis
12.2 Vaccine Adjuvants Key Raw Materials and Upstream Suppliers
12.3 Vaccine Adjuvants Clients Analysis
12.4 Vaccine Adjuvants Sales Channel and Sales Model Analysis
12.4.1 Vaccine Adjuvants Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Vaccine Adjuvants Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Vaccine Adjuvants Distributors
13 Market Dynamics
13.1 Vaccine Adjuvants Market Drivers
13.2 Vaccine Adjuvants Market Opportunities
13.3 Vaccine Adjuvants Market Challenges
13.4 Vaccine Adjuvants Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Vaccine Adjuvants Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Oral
    Table 3. Major Manufacturers of Subcutaneous
    Table 4. Major Manufacturers of Intramuscular
    Table 5. Major Manufacturers of Others
    Table 6. Global Vaccine Adjuvants Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 7. Global Vaccine Adjuvants Market Size by Region (US$ Million): 2021 VS 2027
    Table 8. Global Vaccine Adjuvants Sales by Region (2016-2021) & (MT)
    Table 9. Global Vaccine Adjuvants Sales Forecast by Region (2022-2027) & (MT)
    Table 10. Global Vaccine Adjuvants Revenue by Region (2016-2021) & (US$ Million)
    Table 11. Global Vaccine Adjuvants Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Vaccine Adjuvants Sales by Manufacturer (2016-2021) & (MT)
    Table 13. Global Vaccine Adjuvants Sales Share by Manufacturer (2016-2021)
    Table 14. Vaccine Adjuvants Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 15. Vaccine Adjuvants Revenue Share by Manufacturer (2016-2021)
    Table 16. Key Manufacturers Vaccine Adjuvants Price (2016-2021) & (USD/Kg)
    Table 17. Ranking of Global Top Vaccine Adjuvants Manufacturers by Revenue (US$ Million) in 2020
    Table 18. Global Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2020)
    Table 20. Vaccine Adjuvants Manufacturers Manufacturing Base Distribution and Headquarters
    Table 21. Manufacturers Vaccine Adjuvants Product Type
    Table 22. Date of International Manufacturers Enter into Vaccine Adjuvants Market
    Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 24. SEPPIC Corporation Information
    Table 25. SEPPIC Description and Business Overview
    Table 26. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 27. SEPPIC Vaccine Adjuvants Product
    Table 28. SEPPIC Vaccine Adjuvants Revenue (US$ Million) and Market Share by Product
    Table 29. SEPPIC Vaccine Adjuvants Revenue (US$ Million) and Market Share by Application
    Table 30. SEPPIC Vaccine Adjuvants Revenue (US$ Million) and Market Share by Geographic Area
    Table 31. SEPPIC Vaccine Adjuvants Revenue (US$ Million) and Market Share by Sales Channel
    Table 32. SEPPIC Recent Development
    Table 33. SDA BIO Corporation Information
    Table 34. SDA BIO Description and Business Overview
    Table 35. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 36. SDA BIO Vaccine Adjuvants Product
    Table 37. SDA BIO Vaccine Adjuvants Revenue (US$ Million) and Market Share by Product
    Table 38. SDA BIO Vaccine Adjuvants Revenue (US$ Million) and Market Share by Application
    Table 39. SDA BIO Vaccine Adjuvants Revenue (US$ Million) and Market Share by Geographic Area
    Table 40. SDA BIO Vaccine Adjuvants Revenue (US$ Million) and Market Share by Sales Channel
    Table 41. SDA BIO Recent Development
    Table 42. Brenntag Biosector Corporation Information
    Table 43. Brenntag Biosector Description and Business Overview
    Table 44. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 45. Brenntag Biosector Vaccine Adjuvants Product
    Table 46. Brenntag Biosector Vaccine Adjuvants Revenue (US$ Million) and Market Share by Product
    Table 47. Brenntag Biosector Vaccine Adjuvants Revenue (US$ Million) and Market Share by Application
    Table 48. Brenntag Biosector Vaccine Adjuvants Revenue (US$ Million) and Market Share by Geographic Area
    Table 49. Brenntag Biosector Vaccine Adjuvants Revenue (US$ Million) and Market Share by Sales Channel
    Table 50. Brenntag Biosector Recent Development
    Table 51. SPI Pharma Corporation Information
    Table 52. SPI Pharma Description and Business Overview
    Table 53. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 54. SPI Pharma Vaccine Adjuvants Product
    Table 55. SPI Pharma Vaccine Adjuvants Revenue (US$ Million) and Market Share by Product
    Table 56. SPI Pharma Vaccine Adjuvants Revenue (US$ Million) and Market Share by Application
    Table 57. SPI Pharma Vaccine Adjuvants Revenue (US$ Million) and Market Share by Geographic Area
    Table 58. SPI Pharma Vaccine Adjuvants Revenue (US$ Million) and Market Share by Sales Channel
    Table 59. SPI Pharma Recent Development
    Table 60. MVP Laboratories Corporation Information
    Table 61. MVP Laboratories Description and Business Overview
    Table 62. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 63. MVP Laboratories Vaccine Adjuvants Product
    Table 64. MVP Laboratories Vaccine Adjuvants Revenue (US$ Million) and Market Share by Product
    Table 65. MVP Laboratories Vaccine Adjuvants Revenue (US$ Million) and Market Share by Application
    Table 66. MVP Laboratories Vaccine Adjuvants Revenue (US$ Million) and Market Share by Geographic Area
    Table 67. MVP Laboratories Vaccine Adjuvants Revenue (US$ Million) and Market Share by Sales Channel
    Table 68. MVP Laboratories Recent Development
    Table 69. Tj Kaiwei Corporation Information
    Table 70. Tj Kaiwei Description and Business Overview
    Table 71. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 72. Tj Kaiwei Vaccine Adjuvants Product
    Table 73. Tj Kaiwei Vaccine Adjuvants Revenue (US$ Million) and Market Share by Product
    Table 74. Tj Kaiwei Vaccine Adjuvants Revenue (US$ Million) and Market Share by Application
    Table 75. Tj Kaiwei Vaccine Adjuvants Revenue (US$ Million) and Market Share by Geographic Area
    Table 76. Tj Kaiwei Recent Development
    Table 77. Novavax Corporation Information
    Table 78. Novavax Description and Business Overview
    Table 79. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 80. Novavax Vaccine Adjuvants Product
    Table 81. Novavax Vaccine Adjuvants Revenue (US$ Million) and Market Share by Product
    Table 82. Novavax Vaccine Adjuvants Revenue (US$ Million) and Market Share by Application
    Table 83. Novavax Vaccine Adjuvants Revenue (US$ Million) and Market Share by Geographic Area
    Table 84. Novavax Recent Development
    Table 85. Zhuoyue Corporation Information
    Table 86. Zhuoyue Description and Business Overview
    Table 87. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 88. Zhuoyue Vaccine Adjuvants Product
    Table 89. Zhuoyue Vaccine Adjuvants Revenue (US$ Million) and Market Share by Product
    Table 90. Zhuoyue Vaccine Adjuvants Revenue (US$ Million) and Market Share by Application
    Table 91. Zhuoyue Vaccine Adjuvants Revenue (US$ Million) and Market Share by Geographic Area
    Table 92. Zhuoyue Recent Development
    Table 93. Aphios Corporation Information
    Table 94. Aphios Description and Business Overview
    Table 95. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 96. Aphios Vaccine Adjuvants Product
    Table 97. Aphios Vaccine Adjuvants Revenue (US$ Million) and Market Share by Product
    Table 98. Aphios Vaccine Adjuvants Revenue (US$ Million) and Market Share by Application
    Table 99. Aphios Vaccine Adjuvants Revenue (US$ Million) and Market Share by Geographic Area
    Table 100. Aphios Recent Development
    Table 101. Global Vaccine Adjuvants Sales by Type (2016-2021) & (MT)
    Table 102. Global Vaccine Adjuvants Sales Forecast by Type (2022-2027) & (MT)
    Table 103. Global Vaccine Adjuvants Revenue by Type (2016-2021) & (US$ Million)
    Table 104. Global Vaccine Adjuvants Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 105. Global Vaccine Adjuvants Sales by Application (2016-2021) & (MT)
    Table 106. Global Vaccine Adjuvants Sales Forecast by Application (2022-2027) & (MT)
    Table 107. Global Vaccine Adjuvants Revenue by Application (2016-2021) & (US$ Million)
    Table 108. Global Vaccine Adjuvants Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 109. North America Vaccine Adjuvants Sales by Country (2016-2021) & (MT)
    Table 110. North America Vaccine Adjuvants Sales by Country (2022-2027) & (MT)
    Table 111. North America Vaccine Adjuvants Revenue by Country (2016-2021) & (US$ Million)
    Table 112. North America Vaccine Adjuvants Revenue by Country (2022-2027) & (US$ Million)
    Table 113. North America Vaccine Adjuvants Sales by Type (2016-2021) & (MT)
    Table 114. North America Vaccine Adjuvants Sales by Application (2016-2021) & (MT)
    Table 115. Asia-Pacific Vaccine Adjuvants Sales by Region (2016-2021) & (MT)
    Table 116. Asia-Pacific Vaccine Adjuvants Sales by Region (2022-2027) & (MT)
    Table 117. Asia-Pacific Vaccine Adjuvants Revenue by Region (2016-2027) & (US$ Million)
    Table 118. Asia-Pacific Vaccine Adjuvants Revenue by Region (2022-2027) & (US$ Million)
    Table 119. Asia-Pacific Vaccine Adjuvants Sales by Type (2016-2021) & (MT)
    Table 120. Asia-Pacific Vaccine Adjuvants Sales by Application (2016-2021) & (MT)
    Table 121. Europe Vaccine Adjuvants Sales by Country (2016-2021) & (MT)
    Table 122. Europe Vaccine Adjuvants Sales by Country (2022-2027) & (MT)
    Table 123. Europe Vaccine Adjuvants Revenue by Country (2016-2021) & (US$ Million)
    Table 124. Europe Vaccine Adjuvants Revenue by Country (2022-2027) & (US$ Million)
    Table 125. Europe Vaccine Adjuvants Sales by Type (2016-2021) & (MT)
    Table 126. Europe Vaccine Adjuvants Sales by Application (2016-2021) & (MT)
    Table 127. Latin America Vaccine Adjuvants Sales by Country (2016-2021) & (MT)
    Table 128. Latin America Vaccine Adjuvants Sales by Country (2022-2027) & (MT)
    Table 129. Latin America Vaccine Adjuvants Revenue by Country (2016-2021) & (US$ Million)
    Table 130. Latin America Vaccine Adjuvants Revenue by Country (2022-2027) & (US$ Million)
    Table 131. Latin America Vaccine Adjuvants Sales by Type (2016-2021) & (MT)
    Table 132. Latin America Vaccine Adjuvants Sales by Application (2016-2021) & (MT)
    Table 133. Middle East and Africa Vaccine Adjuvants Sales by Country (2016-2021) & (MT)
    Table 134. Middle East and Africa Vaccine Adjuvants Sales by Country (2022-2027) & (MT)
    Table 135. Middle East and Africa Vaccine Adjuvants Revenue by Country (2016-2021) & (US$ Million)
    Table 136. Middle East and Africa Vaccine Adjuvants Revenue by Country (2022-2027) & (US$ Million)
    Table 137. Middle East and Africa Vaccine Adjuvants Sales by Type (2016-2021) & (MT)
    Table 138. Middle East and Africa Vaccine Adjuvants Sales by Application (2016-2021) & (MT)
    Table 139. Vaccine Adjuvants Key Raw Materials, Industry Status and Trend
    Table 140. Vaccine Adjuvants Key Raw Materials and Upstream Suppliers
    Table 141. Vaccine Adjuvants Clients Status and Trend
    Table 142. Vaccine Adjuvants Typical Clients
    Table 143. Vaccine Adjuvants Distributors
    Table 144. Key Drivers: Impact Analysis (2022-2027)
    Table 145. Vaccine Adjuvants Market Drivers
    Table 146. Vaccine Adjuvants Market Opportunities
    Table 147. Vaccine Adjuvants Market Challenges
    Table 148. Vaccine Adjuvants Market Restraints
    Table 149. Vaccine Adjuvants Porter’s Five Forces Analysis
    Table 150. Research Programs/Design for This Report
    Table 151. Key Data Information from Secondary Sources
    Table 152. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vaccine Adjuvants Product Picture
    Figure 2. Global Vaccine Adjuvants Sales Market Share by Type in 2021 & 2027
    Figure 3. Oral Product Picture
    Figure 4. Subcutaneous Product Picture
    Figure 5. Intramuscular Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Vaccine Adjuvants Sales Market Share by Application in 2021 & 2027
    Figure 8. Human Vaccine Adjuvants Examples
    Figure 9. Veterinary Vaccine Adjuvants Examples
    Figure 10. Vaccine Adjuvants Report Years Considered
    Figure 11. Global Vaccine Adjuvants Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Vaccine Adjuvants Market Size 2016-2027 (US$ Million)
    Figure 13. Global Vaccine Adjuvants Sales 2016-2027 (K Units)
    Figure 14. Global Vaccine Adjuvants Market Size Market Share by Region: 2021 Versus 2027
    Figure 15. Global Vaccine Adjuvants Sales Market Share Forecast by Region (2016-2027)
    Figure 16. Global Vaccine Adjuvants Revenue Market Share by Region (2016-2027)
    Figure 17. Global Vaccine Adjuvants Sales Share by Manufacturer in 2020
    Figure 18. Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 19. Global Vaccine Adjuvants Sales Market Share Forecast by Type (2016-2027)
    Figure 20. Global Vaccine Adjuvants Revenue Market Share Forecast by Type (2016-2027)
    Figure 21. Vaccine Adjuvants Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 22. Global Vaccine Adjuvants Sales Market Share Forecast by Application (2016-2027)
    Figure 23. Global Vaccine Adjuvants Revenue Market Share Forecast by Application (2016-2027)
    Figure 24. Vaccine Adjuvants Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 25. North America Vaccine Adjuvants Revenue 2016-2027 (US$ Million)
    Figure 26. North America Vaccine Adjuvants Sales Market Share by Type (2016-2021)
    Figure 27. North America Vaccine Adjuvants Sales Market Share by Application (2016-2021)
    Figure 28. Asia-Pacific Vaccine Adjuvants Revenue 2016-2027 (US$ Million)
    Figure 29. Asia-Pacific Vaccine Adjuvants Sales Market Share by Region (2016-2027)
    Figure 30. Asia-Pacific Vaccine Adjuvants Revenue Market Share by Region (2016-2027)
    Figure 31. Asia-Pacific Vaccine Adjuvants Sales Market Share by Type (2016-2021)
    Figure 32. Asia-Pacific Vaccine Adjuvants Sales Market Share by Application (2016-2021)
    Figure 33. Europe Vaccine Adjuvants Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 34. Europe Vaccine Adjuvants Sales Market Share by Country (2016-2027)
    Figure 35. Europe Vaccine Adjuvants Revenue Market Share by Country (2016-2027)
    Figure 36. Europe Vaccine Adjuvants Sales Market Share by Type (2016-2021)
    Figure 37. Europe Vaccine Adjuvants Sales Market Share by Application (2016-2021)
    Figure 38. Latin America Vaccine Adjuvants Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 39. Latin America Vaccine Adjuvants Sales Market Share by Country (2016-2027)
    Figure 40. Latin America Vaccine Adjuvants Revenue Market Share by Country (2016-2021)
    Figure 41. Latin America Vaccine Adjuvants Sales Market Share by Type (2016-2021)
    Figure 42. Latin America Vaccine Adjuvants Sales Market Share by Application (2016-2021)
    Figure 43. Middle East and Africa Vaccine Adjuvants Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 44. Middle East and Africa Vaccine Adjuvants Sales Market Share by Country (2016-2027)
    Figure 45. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Country (2016-2027)
    Figure 46. Middle East and Africa Vaccine Adjuvants Sales Market Share by Type (2016-2021)
    Figure 47. Middle East and Africa Vaccine Adjuvants Sales Market Share by Application (2016-2021)
    Figure 48. Vaccine Adjuvants Supply Chain (Upstream and Downstream Market)
    Figure 49. Global Production Market Share of Vaccine Adjuvants Raw Materials by Region in 2020
    Figure 50. Vaccine Adjuvants Distribution Channels
    Figure 51. Global Vaccine Adjuvants Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 52. Global Vaccine Adjuvants Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 53. Porter's Five Forces Analysis
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows multiple user to access the PDF.

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

China Autogenous Vaccines Market Report Forecast 2021 2027
China Autogenous Vaccines Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-22Z1818
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Flu Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Flu Vaccine market size was US 5154 million and it is expected to reach US 7293.3 million by the end of 2027 with a CAGR of 4.8 during 20212027.Global Flu Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-11H675
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global Rabies Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

And in terms of application the largest application is Postexposure Prophylaxis followed by Preexposure Prophylaxis.Market Analysis and Insights Global Rabies Vaccine MarketIn 2020 the global Rabies Vaccine market size was US 877 million and it is expected to reach US 1178 million by the end of 2027 with a CAGR of 4.0 during 20212027.Global Rabies Vaccin.

120 Pages
Type: Report
Code: QYRE-Auto-34M23
Mon Sep 27 00:00:00 UTC 2021

Add to Cart

Global and United States Sulfachloropyridazine Sodium Market Insights Forecast to 2027
Global and United States Sulfachloropyridazine Sodium Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-28M6619
Tue Sep 21 00:00:00 UTC 2021

Add to Cart